Karen McGrath - Paratek Pharmaceuticals VP HR

PRTKDelisted Stock  USD 2.18  0.00  0.00%   

Insider

Karen McGrath is VP HR of Paratek Pharmaceuticals
Phone617 807 6600
Webhttps://paratekpharma.com

Paratek Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Paratek Pharmaceuticals' management efficiency ratios could be used to measure how well Paratek Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
Paratek Pharmaceuticals currently holds 258.41 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Paratek Pharmaceuticals has a current ratio of 3.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Paratek Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Walter NewmanLeap Therapeutics
78
Alan EsqCorvus Pharmaceuticals
N/A
Krishna MDEquillium
51
Joanna BrewerAdaptimmune Therapeutics Plc
48
Joern AldagHookipa Pharma
65
Marine PopoffHookipa Pharma
N/A
Denise MuellerAffimed NV
54
Christian MuellerImmutep Ltd ADR
N/A
Mark OMahonyLeap Therapeutics
53
Uwe ReuschAffimed NV
N/A
Carol ZoltowskiJasper Therapeutics
74
Reinhard KanderaHookipa Pharma
55
Pr LittleAffimed NV
N/A
Richard MDCorvus Pharmaceuticals
73
Angus SmithAffimed NV
42
Janet CAAptose Biosciences
N/A
Jason CavalierLyra Therapeutics
51
Susan ProhaskaJasper Therapeutics
N/A
Margaret HenryAdaptimmune Therapeutics Plc
N/A
Helen MBAAdaptimmune Therapeutics Plc
57
Andreas BergthalerHookipa Pharma
N/A
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts. Paratek Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people. Paratek Pharmaceuticals (PRTK) is traded on NASDAQ Exchange in USA and employs 268 people.

Management Performance

Paratek Pharmaceuticals Leadership Team

Elected by the shareholders, the Paratek Pharmaceuticals' board of directors comprises two types of representatives: Paratek Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paratek. The board's role is to monitor Paratek Pharmaceuticals' management team and ensure that shareholders' interests are well served. Paratek Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paratek Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Ex Chairman
FACC FAHA, CEO Director
Karen McGrath, VP HR
Sarah Higgins, Interim Principal Financial Officer and Principal Accounting Officer
Ben Strain, VP CEO
William Haskel, Senior Vice President General Counsel, Corporate Secretary
Adam Woodrow, Vice President and Chief Commercial Officer
Jason Burdette, VP Operations
Randall Brenner, Chief Officer

Paratek Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Paratek Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Paratek Stock

If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data